• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据日本肺癌登记联合委员会的数据,日本肺癌患者的预后情况。

Prognosis of lung cancer patients in Japan according to data from the Japanese Joint Committee of Lung Cancer Registry.

作者信息

Sawabata Noriyoshi

机构信息

General Thoracic Surgery, Hoshigaoka Medical Center, Japan Community Health Care Organization, 4-8-1 Hoshigaoka, Hirakata City, Osaka 573-8511, Japan; Osaka University Graduate School of Medicine, 2-7 Yamadaoka, Suita City, Osaka 565-0871, Japan.

出版信息

Respir Investig. 2014 Nov;52(6):317-21. doi: 10.1016/j.resinv.2014.04.002. Epub 2014 Jun 17.

DOI:10.1016/j.resinv.2014.04.002
PMID:25453374
Abstract

An organ-based lung cancer registry is currently maintained by the Japan Joint Committee of Lung Cancer Registry; this registry contributes to the development of lung cancer treatments and provides TNM classification data. In Japan, the overall 5-year survival rate has improved over time to 52% in 2004; the corresponding rates for each pathologic stage have also improved. Previously, separate registries were maintained for surgical and non-biased cases, whereas a prospective registry for non-surgical cases was added in 2012, and a follow-up examination of those data will be conducted in 2016. In addition, a registry of surgical cases from 2010 will be constructed in 2016. The information provided by these registries should better reveal the status of lung cancer patients in Japan.

摘要

日本肺癌登记联合委员会目前维护着一个基于器官的肺癌登记系统;该登记系统有助于肺癌治疗的发展,并提供TNM分类数据。在日本,总体5年生存率随时间推移有所提高,2004年达到了52%;各病理阶段的相应生存率也有所提高。以前,手术病例和非偏倚病例分别有登记系统,而2012年增加了非手术病例的前瞻性登记系统,2016年将对这些数据进行随访检查。此外,2016年将构建2010年以来手术病例的登记系统。这些登记系统提供的信息应能更好地揭示日本肺癌患者的状况。

相似文献

1
Prognosis of lung cancer patients in Japan according to data from the Japanese Joint Committee of Lung Cancer Registry.根据日本肺癌登记联合委员会的数据,日本肺癌患者的预后情况。
Respir Investig. 2014 Nov;52(6):317-21. doi: 10.1016/j.resinv.2014.04.002. Epub 2014 Jun 17.
2
Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.日本6644例非小细胞肺癌切除病例的预后:一项日本肺癌登记研究
Lung Cancer. 2005 Nov;50(2):227-34. doi: 10.1016/j.lungcan.2005.05.021. Epub 2005 Aug 2.
3
Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.2010 年日本肺癌登记数据库联合委员会 18973 例手术病例中第七版和第八版 TNM 分类的人口统计学、安全性和质量以及预后信息。
J Thorac Oncol. 2019 Feb;14(2):212-222. doi: 10.1016/j.jtho.2018.10.002. Epub 2018 Oct 10.
4
Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004.2004 年日本肺癌注册中心 243 例小细胞肺癌患者的回顾性分析
J Thorac Oncol. 2014 Aug;9(8):1140-5. doi: 10.1097/JTO.0000000000000226.
5
A clinical statistical study of lung cancer patients in Japan with special reference to the staging system of TNM classification: a report from the Japan Joint Committee of Lung Cancer associated with the TNM System of Clinical Classification (UICC).日本肺癌患者的临床统计学研究:特别参考TNM分类分期系统——来自与TNM临床分类系统(国际抗癌联盟)相关的日本肺癌联合委员会的报告
Radiat Med. 1983 Apr-Jun;1(2):186-95.
6
Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: the influence of positive pleural lavage cytology results on T classification.术中胸膜腔灌洗细胞学检查对非小细胞肺癌的预后价值:阳性胸膜腔灌洗细胞学结果对T分期的影响
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2659-64. doi: 10.1016/j.jtcvs.2014.07.090. Epub 2014 Aug 6.
7
How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations.肺癌的TNM分期系统应如何修订?基于日本肺癌登记人群的模拟研究。
J Thorac Cardiovasc Surg. 2006 Aug;132(2):316-9. doi: 10.1016/j.jtcvs.2006.03.048.
8
[Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004].[日本的肺癌:对2004年切除的肺癌登记病例的分析]
Nihon Kokyuki Gakkai Zasshi. 2011 Apr;49(4):327-42.
9
Modern surgical results of lung cancer involving neighboring structures: a retrospective analysis of 531 pT3 cases in a Japanese Lung Cancer Registry Study.肺癌累及毗邻结构的现代外科治疗结果:日本肺癌注册研究中 531 例 pT3 病例的回顾性分析。
J Thorac Cardiovasc Surg. 2012 Aug;144(2):431-7. doi: 10.1016/j.jtcvs.2012.05.069. Epub 2012 Jun 19.
10
Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: the Japanese Lung Cancer Registry Study 2004.50 岁以下肺癌患者的临床病理特征和手术结果:日本肺癌登记研究 2004 年报告。
Lung Cancer. 2014 Feb;83(2):246-51. doi: 10.1016/j.lungcan.2013.11.007. Epub 2013 Nov 17.

引用本文的文献

1
LncRNA FAM66C predicts poor prognosis in patients with lung adenocarcinoma and regulates cell proliferation and metastasis via miR-339-3p.长链非编码RNA FAM66C预测肺腺癌患者预后不良,并通过miR-339-3p调节细胞增殖和转移。
J Cardiothorac Surg. 2025 Apr 2;20(1):175. doi: 10.1186/s13019-025-03374-1.
2
Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study.在日本真实环境下可切除的 IIIA 期非小细胞肺癌的治疗模式和临床结局:SOLUTION 研究的手术队列分析。
Thorac Cancer. 2024 Jul;15(20):1541-1552. doi: 10.1111/1759-7714.15305. Epub 2024 May 29.
3
Should sublobar resection be offered for screening-detected lung nodules?
对于筛查发现的肺结节,是否应进行肺段以下切除术?
Transl Lung Cancer Res. 2021 May;10(5):2418-2426. doi: 10.21037/tlcr.2020.04.06.
4
Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy.接受姑息性胸部放射治疗后接受免疫检查点抑制剂治疗的肺癌患者中肺炎的发生率和危险因素。
J Radiat Res. 2021 Jul 10;62(4):669-675. doi: 10.1093/jrr/rrab051.
5
The utility of transbronchial rebiopsy for peripheral pulmonary lesions in patients with advanced non-squamous non-small cell lung cancer.经支气管镜肺活检对晚期非鳞状非小细胞肺癌周围性肺部病变的应用价值。
BMC Pulm Med. 2020 Sep 9;20(1):238. doi: 10.1186/s12890-020-01277-6.
6
The Role of Upregulated as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma.上调作为肺腺癌潜在的预后和诊断生物标志物的作用。
J Cancer. 2019 Jul 10;10(18):4208-4216. doi: 10.7150/jca.33457. eCollection 2019.
7
Diagnostic efficacy of broncho-alveolar lavage carcino-embronic antigen in carcinoma of lung.支气管肺泡灌洗癌胚抗原在肺癌诊断中的效能
J Family Med Prim Care. 2019 May;8(5):1725-1729. doi: 10.4103/jfmpc.jfmpc_119_19.
8
MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2.MicroRNA-130b 通过靶向金属蛋白酶组织抑制剂 2 在非小细胞肺癌中发挥癌基因作用。
Sci Rep. 2019 May 6;9(1):6956. doi: 10.1038/s41598-019-43355-8.
9
High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma.术前血浆血管抑制素-1浓度高预示非小细胞肺癌患者预后较好。
Health Sci Rep. 2018 May 17;1(6):e40. doi: 10.1002/hsr2.40. eCollection 2018 Jun.
10
Clinical Implications of Transbronchial Biopsy for Surgically-resected Non-small Cell Lung Cancer.经支气管活检对手术切除的非小细胞肺癌的临床意义
In Vivo. 2018 May-Jun;32(3):691-698. doi: 10.21873/invivo.11295.